rs1495741, None

N. diseases: 9
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Triglycerides measurement
CUI: C0202236
Disease: Triglycerides measurement
1418 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.800 1.000 4 2010 2019
Serum total cholesterol measurement
CUI: C1445957
Disease: Serum total cholesterol measurement
1243 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.800 1.000 3 2010 2018
Carcinoma of bladder
CUI: C0699885
Disease: Carcinoma of bladder
309 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.720 1.000 4 2010 2016
Malignant neoplasm of urinary bladder
316 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.720 1.000 4 2010 2016
Tuberculosis
CUI: C0041296
Disease: Tuberculosis
328 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.710 1.000 2 2016 2019
Chemical and Drug Induced Liver Injury
38 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.700 1.000 1 2019 2019
Drug-Induced Liver Disease
CUI: C0860207
Disease: Drug-Induced Liver Disease
29 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.030 1.000 3 2013 2017
Bladder Neoplasm
CUI: C0005695
Disease: Bladder Neoplasm
281 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.020 1.000 2 2014 2016
Caffeine related disorders
CUI: C0236734
Disease: Caffeine related disorders
56 0.827 0.240 8 18415371 regulatory region variant G/A snv 0.71 0.010 1.000 1 2015 2015